Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP250961.RAXYnSAbeTWwToWAidsCtHGcxp7yUo1-sSE9-k3iHK9H4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP250961.RAXYnSAbeTWwToWAidsCtHGcxp7yUo1-sSE9-k3iHK9H4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP250961.RAXYnSAbeTWwToWAidsCtHGcxp7yUo1-sSE9-k3iHK9H4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP250961.RAXYnSAbeTWwToWAidsCtHGcxp7yUo1-sSE9-k3iHK9H4130_provenance.
- NP250961.RAXYnSAbeTWwToWAidsCtHGcxp7yUo1-sSE9-k3iHK9H4130_assertion wasGeneratedBy ECO_0000203 NP250961.RAXYnSAbeTWwToWAidsCtHGcxp7yUo1-sSE9-k3iHK9H4130_provenance.
- NP250961.RAXYnSAbeTWwToWAidsCtHGcxp7yUo1-sSE9-k3iHK9H4130_assertion wasDerivedFrom befree-20140225 NP250961.RAXYnSAbeTWwToWAidsCtHGcxp7yUo1-sSE9-k3iHK9H4130_provenance.
- NP250961.RAXYnSAbeTWwToWAidsCtHGcxp7yUo1-sSE9-k3iHK9H4130_assertion SIO_000772 17568789 NP250961.RAXYnSAbeTWwToWAidsCtHGcxp7yUo1-sSE9-k3iHK9H4130_provenance.
- NP250961.RAXYnSAbeTWwToWAidsCtHGcxp7yUo1-sSE9-k3iHK9H4130_assertion evidence source_evidence_literature NP250961.RAXYnSAbeTWwToWAidsCtHGcxp7yUo1-sSE9-k3iHK9H4130_provenance.
- NP250961.RAXYnSAbeTWwToWAidsCtHGcxp7yUo1-sSE9-k3iHK9H4130_assertion description "[To address disease heterogeneity in RA FLS cells, we examined the effects of clinical disease parameters (Health Assessment Questionnaire (HAQ) score, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), rheumatoid factor (RF)) and drug therapies (methotrexate/prednisone) on RA FLS cell gene expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP250961.RAXYnSAbeTWwToWAidsCtHGcxp7yUo1-sSE9-k3iHK9H4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP250961.RAXYnSAbeTWwToWAidsCtHGcxp7yUo1-sSE9-k3iHK9H4130_provenance.